Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 2Suspended 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2

Conditions

Lymphoma, Large B-Cell, Diffuse 43Breast Neoplasms 30Lymphoma 28Sarcoma 26Hodgkin Disease 24Triple Negative Breast Neoplasms 20Burkitt Lymphoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Follicular 16Neoplasms 15Ovarian Neoplasms 14Lymphoma, Non-Hodgkin 13Lymphoma, B-Cell 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell, Peripheral 9Endometrial Neoplasms 9Neuroblastoma 7Neoplasm Metastasis 7Lymphoma, Mantle-Cell 7Liposarcoma 7Leukemia 7Fallopian Tube Neoplasms 7Recurrence 6Multiple Myeloma 6Leiomyosarcoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Inflammatory Breast Neoplasms 5Histiocytoma, Malignant Fibrous 5

Interventions

Paclitaxel 8Hyperthermic Intraperitoneal Chemotherapy 6Mitomycin 5Cisplatin 5Fluorouracil 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Doxorubicin 3Cytoreduction Surgical Procedures 3Carboplatin 3Blood Specimen Collection 3sodium thiosulfate 2pembrolizumab 2Standard of Care 2Laparoscopy 2soluble LAG-3 protein, human 1relacorilant 1oregovomab 1olaparib 1nilotinib 1liposomal doxorubicin 1irinotecan sucrosofate 1dehydroftorafur 1avelumab 1X-Rays 1Topotecan 1Taxes 1Specimen Handling 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Peritoneal Neoplasms × Doxorubicin × 1 year × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT03875144 2026-02-09

MESOTIP

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Suspended
66 enrolled
Gynecologic

Peritoneal Neoplasms

NCT04329494 2025-12-10

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center

Phase 1 Recruiting
49 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡